Adam Walker’s Pharma Prescribed Podcast

By Adam Walker

Get ready for open and honest long-form conversations with fascinating and passionate individuals in clinical research.
These are people you may or may not be aware of, with one thing in common - ... more

Download on the App Store

Download on the App Store

Get it on Google Play

FAQs about Adam Walker’s Pharma Prescribed Podcast:

How many episodes does Adam Walker’s Pharma Prescribed Podcast have?

The podcast currently has 55 episodes available.

Adam Walker’s Pharma Prescribed Podcast episodes:

December 11, 2025 The Navy Leadership Rule Most Pharma Bosses Get Wrong
Alan Salter on Military Service, Servant Leadership & Brilliance at the Basics | Pharma Prescribed
Alan Salter — Navy veteran, management consultant and co-founder of Nonprofit Resource Partners — joins Adam Walker for a grounded, values-driven conversation about service, leadership and the art of being brilliant at the basics.
Alan is third-generation military. His grandfather drove tanks with Patton in World War II. His dad was a pharmacist-turned-Army-colonel. Alan joined the Navy, built a warship from the keel up, then took everything the military taught him into GE, Black & Decker, Takeda and eventually his own consulting practice.
This episode is about what happens when you spend a career choosing purpose over paycheque.
🎧 LISTEN ON YOUR PREFERRED APP
Spotify → https://open.spotify.com/episode/37t50x6goQXlaIJaAFhqIf?si=hW93YEmCR4WW-B4XwN9uCQ
Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-with-alan-salter-navigating-change/id1829715970?i=1000740872966
Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
Podbean → https://www.podbean.com/ew/pb-psbuj-19df9c4
📖 WHAT WE COVER
- The Army brat who joined the Navy — and what that says about Alan
- Building an LHD warship: 17 months, 2,000 Marines and the crowning military achievement
- Being 23 with 50 people and $150 million in inventory — zero margin for error
- Why healthcare gave him purpose that CPG never could
- Nonprofit Resource Partners: fractional staffing for nonprofits at affordable rates
- The partner running a nonprofit in a "fire pit" — and why that's exactly the point
- Veteran ERGs at Takeda: the instant bond of shared life experience
- "Be brilliant at the basics" — the advanced settings button means nothing if you don't
- AI as enhancement not answer: checking every ChatGPT output before sending
- Are we dumbing ourselves down by outsourcing thinking to AI?
- Curious, connected, courageous: the three Cs from a former Marine VP
- Colour energies, Myers-Briggs and working on yourself through failure
- Ethics and total transparency: delivering the bad news is where courage lives
⏱️ CHAPTERS
0:00 Introduction & podcast mission
1:00 Meet Alan Salter — Navy veteran and consultant
2:00 The Army brat who joined the Navy
3:00 From Navy to GE to Black & Decker to healthcare
4:00 Finding purpose — why healthcare beat CPG
5:00 Building a warship: 17 months, 2,000 Marines
6:00 Being 23 with $150 million in inventory
7:00 Transferable skills: structure, leadership, being the fixer
8:00 Project management as a military inheritance
9:00 The instant bond of shared military experience
10:00 Veteran ERGs at Takeda — still friends 11 years later
11:00 Caravel International Partners and Nonprofit Resource Partners
12:00 How NRP works: fractional staffing for 501(c)(3) organisations
13:00 Finding leads through referral partnerships
14:00 The Hawaii call and four volunteers in 24 hours
15:00 The partner in the nonprofit fire pit
16:00 What's a 501(c)(3) and who NRP serves
17:00 Service as a way of life: purpose over paycheque
18:00 Servant leadership — it's not a LinkedIn bio, it's how I live
19:00 Third generation military: grandfather with Patton, dad the pharmacist-colonel
20:00 Core memories: the tanker jacket and World War II paraphernalia
21:00 Mentorship by example and the mutual introduction
22:00 Be brilliant at the basics — don't skip to advanced settings
23:00 World class basics and turning every page
24:00 AI tools as enhancement not answer
25:00 Checking every AI note taker summary before sending
26:00 ChatGPT as starting point — then adding your own spin
27:00 Are we dumbing ourselves down?
28:00 Tools as enhancements, not the 100% answer
29:00 Skynet and the moment humans leave the loop
30:00 Working on yourself: colour energies and self-awareness
31:00 Being high-red and learning to moderate it
32:00 The 7 Habits: sharpen the saw
33:00 Reading the room and leveraging team strengths
34:00 Quick-fire: be more bold
35:00 Curious, connected, courageous — the three Cs
36:00 Camping, foodies and going back to the cinema
37:00 The popcorn cruncher
38:00 Ethics, transparency and ruthless honesty
39:00 Closing thanks
👤 ABOUT ALAN SALTER
Alan Salter is a US Navy veteran and founder of Caravel International Partners (management consulting) and co-founder of Nonprofit Resource Partners. Former operations and supply chain leader at Takeda, Black & Decker and GE. Based in Chicago.
💼 Search "Alan Salter" on LinkedIn
🎙️ ABOUT PHARMA PRESCRIBED
Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
🌐 https://pharmaprescribed.com
💼 https://www.linkedin.com/in/adam-walker-2327951/
#AlanSalter #NavyVeteran #ServantLeader #PharmaPrescribed #AdamWalker #NonprofitResourcePartners #VeteransInHealthcare #ProjectManagement #Takeda #AITools #BrilliantAtTheBasics #Leadership #ServiceMindset #LifeSciences #Chicago
...more
39min
December 08, 2025 Stop Designing Clinical Trials for Patients Who Don't Exist
Maya Zlatanova on Designing Trials for Real Patients (Not Unicorns) | Pharma Prescribed
Maya Zlatanova — CEO and co-founder of Find Me Cure and Trial Hub — joins Adam Walker for one of the most human and high-stakes conversations on the Pharma Prescribed Podcast.
Maya studied history and geography in Bulgaria, became a mom, watched her sister battle a disease with no standard of care, and decided someone needed to fix the part of clinical research that everyone knew was broken. Ten years later she's built two platforms — one for patients, one for sponsors — and won the Dharmala Award for an AI tool that maps patient journeys across 76 countries.
She designs trials for real patients. Not unicorns.
🎧 LISTEN ON YOUR PREFERRED APP
Spotify → https://open.spotify.com/episode/2ILbTxvk5jQZIqmduieIFr?si=Cwm3pv0FRDy_NKqzYws83Q
Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-with-maya-zlatanova-ceo-of/id1829715970?i=1000740219842
Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
Podbean → https://www.podbean.com/ew/pb-4mefu-19dc10e
📖 WHAT WE COVER
- Growing up in Bulgaria: why failing at 18 was the greatest gift
- Her sister's disease with no standard of care — the personal why behind everything
- The iceberg: solving visible recruitment problems vs the structural ones sinking trials
- Why patient awareness alone doesn't work — and the pivot that changed everything
- Find Me Cure: the world's largest clinical trial database, built for patients, run as an NGO
- Trial Hub: helping sponsors design smarter, more patient-feasible trials
- "Trials for real patients, not unicorns" — the Dharmala stage speech
- 80-90% of trials fail or delay — and it hasn't changed in 20 years
- The Germany problem: why offering placebo to patients with reimbursed treatment is doomed
- AI patient journey mapping across 76 countries in seconds
- Why patient feasibility must happen before statistical planning
- The dance: how you lead change in a resistant industry
- Collaboration over competition: tell me your real pain
- Just one golden rule — one word
⏱️ CHAPTERS
0:00 Introduction & podcast mission
1:00 Meet Maya Zlatanova — co-founder of Find Me Cure and Trial Hub
2:00 "I'm not a visionary — I'm a normal human being"
3:00 Growing up in Bulgaria — history, geography and first big failure
4:00 What failure at 18 taught her about effort
5:00 Her sister's disease — and becoming a mom at the same time
6:00 The moment clinical trials became personal
7:00 The iceberg: visible problems vs deep structural ones
8:00 Where to put your effort for real impact
9:00 Why patient awareness alone doesn't change trial outcomes
10:00 The pivot: from patient education to trial design
11:00 How to measure impact in clinical trials
12:00 The zip code lottery and schedule barriers for patients
13:00 80-90% of trials delayed — same number for 20 years
14:00 Shaping trial design vs chasing patients who don't fit
15:00 Find Me Cure: the world's largest clinical trial database
16:00 Connecting patients with sites, doctors and investigators
17:00 Trial Hub: the sponsor and CRO platform
18:00 Patient feasibility tools and blind spots in clinical development
19:00 Trials for real patients, not unicorns — the Dharmala speech
20:00 Smarter people in the room — the sports team model
21:00 Radical candor with clients and collaborators
22:00 The unicorn analogy: protocols for patients who don't exist
23:00 Germany, placebo and local standard of care
24:00 AI patient journey mapping: 76 countries, all indications
25:00 Why patient feasibility comes before statistical planning
26:00 The future: AI as a tool, not AI for its own sake
27:00 Changing habits — including Maya's own resistance
28:00 The dance: leading change in a resistant industry
29:00 Collaboration as the third requirement
30:00 Quick-fire: trust your gut
31:00 Transparency, proactivity and focus
32:00 Dancing — and piano lessons now too
33:00 Golden rule: grow — and the hearts on Maya's jumper
34:00 Closing thanks
👤 ABOUT MAYA ZLATANOVA
Maya Zlatanova is CEO and co-founder of Find Me Cure and Trial Hub. Winner of the Dharmala Award for AI innovation. Host of Trials with Maya Z podcast.
🌐 https://www.findmecure.com
🌐 https://www.trialhub.com
💼 Search "Maya Zlatanova" on LinkedIn
🎙️ ABOUT PHARMA PRESCRIBED
Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
🌐 https://pharmaprescribed.com
💼 https://www.linkedin.com/in/adam-walker-2327951/
#MayaZlatanova #FindMeCure #TrialHub #ClinicalTrials #PatientRecruitment #PharmaPrescribed #AdamWalker #PatientCentric #TrialDesign #AIinPharma #ClinicalResearch #PatientFeasibility #DrugDevelopment #LifeSciences #Bulgaria
...more
36min
December 01, 2025 The 'Research Deserts' Where a Clinical Trial Will Never Reach You
Dr. Daniel Fox on Research Deserts & Building CRPN to Fix Clinical Trial Access | Pharma Prescribed
Dr. Daniel Fox — CEO of CRPN (Clinical Research Payment Network) — joins Adam Walker for the most emotionally raw and structurally radical conversation on the Pharma Prescribed Podcast.
Daniel is a PhD scientist, former CRA and director of clinical research who has worked every side of the industry. He is also the father of Violet, who died of I-cell disease (mucolipidosis) on Christmas morning, aged three, weeks before COVID. There was no trial near enough to help her.
That loss became his life's mission. CRPN exists because of Violet.
🎧 LISTEN ON YOUR PREFERRED APP
Spotify → https://open.spotify.com/episode/6t8KOSIeEao91fwI2sHeUq?si=ytbgsw37TaCjeQBcjMVKoA
Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-with-dr-daniel-fox-ceo-of-crpn/id1829715970?i=1000739126936
Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
Podbean → https://www.podbean.com/ew/pb-7d97e-19d6c58
📖 WHAT WE COVER
- Violet's diagnosis: I-cell disease, the geneticist who had only seen three cases, the four-to-six year life expectancy
- Christmas morning, 5am — and a sister who still believed in Santa
- Aaron's Pavilion: the park, the bench and strangers united by the same disease
- Why people are still dying because they can't access trials — in 2025
- The dirty secret of DCTs: the regulation is solved, the payment model isn't
- CRPN: treating sponsors like insurance cards and sites like healthcare clinics
- Cutting 8–18 months of contract negotiation with pre-fixed in-network rates
- Claims-style payment: how healthcare pays and how research must mirror it
- Autism after school: the cliff edge no one talks about
- Kohl's Goals: the children's book illustrated by a paid autistic adult
- ACEs training: autism-conscious businesses changing community life
- The Four Agreements: the book that rewired everything
⏱️ CHAPTERS
0:00 Introduction & podcast mission
1:00 Meet Dr. Daniel Fox — CEO of CRPN
2:00 The mission: everyone who needs a trial should have access
3:00 Why geography is killing patients in 2025
4:00 How the system breaks between drug development and patient access
5:00 The research desert: Daniel's own story begins
6:00 Violet's diagnosis: I-cell disease
7:00 What I-cell does to a child's cells
8:00 Moving from California to Illinois — to be near family for what was coming
9:00 The director job posted the day they decided to move
10:00 Watching Violet die while managing clinical trials
11:00 "I'll carry her impact through me"
12:00 Christmas morning: Violet died at 5am — Scarlet still believed in Santa
13:00 Aaron's Pavilion and the bench with Violet's name
14:00 Two weeks before COVID — Violet's celebration of life
15:00 No more lost life because of access — the CRPN mission
16:00 Healthcare is worth trillions; research worth billions — that's the problem
17:00 Sharing grief — why this conversation matters to Adam too
18:00 Doing your best to avoid regret
19:00 CRPN: the long-term and short-term vision
20:00 Eight to eighteen months of negotiation — before a single patient is seen
21:00 The fixed contract and the sponsor amendment problem
22:00 How healthcare clinics actually get paid
23:00 The in-network insurance card model for clinical research
24:00 Pre-fixed rates and IRB submission on day one
25:00 Claims-style payments: validate, pay the site, chase the sponsor
26:00 The patient trial card: any doctor's office, anywhere
27:00 Autism after school: Violet's OT and the idea
28:00 Innovation Autism and the post-school cliff edge
29:00 Kohl's Goals: illustrated by a paid autistic adult
30:00 ACEs training and parents no longer afraid to go out
31:00 Autistic people as superpowers in any team
32:00 Are autism rates rising — or just identification?
33:00 Screen time, boredom and a Dr. Fox theory
34:00 Rare diseases and the I-cell cat colony that ran out of funding
35:00 CRPN plan B: guiding community research sites through chaos
36:00 Quick-fire: The Four Agreements
37:00 Honesty, communication and impact
38:00 Karate and a strong mind
39:00 Golden rule: you walk through life alone
40:00 Closing thanks and how to connect
👤 ABOUT DR. DANIEL FOX
Dr. Daniel Fox is CEO of CRPN (Clinical Research Payment Network). PhD scientist, former CRA and director of clinical research. Father of Violet.
💼 Search "Daniel Fox CRPN" on LinkedIn
📺 YouTube: Search "CRPN Daniel Fox"
🎙️ ABOUT PHARMA PRESCRIBED
Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
🌐 https://pharmaprescribed.com
💼 https://www.linkedin.com/in/adam-walker-2327951/
#DanielFox #CRPN #ClinicalResearch #PatientAccess #PharmaPrescribed #AdamWalker #DecentralisedTrials #RareDisease #IcellDisease #Mucolipidosis #Autism #ClinicalTrials #ResearchDesert #DrugDevelopment #LifeSciences
...more
47min
November 21, 2025 He Did Everything Right and Still Broke Down: The Crisis in Men's Health
Ryan Parke on Testosterone, Suicide & Why Doing Everything Still Wasn't Enough | Pharma Prescribed
⚠️ This episode discusses suicide and men's mental health. Samaritans → 116 123 (UK, free, 24/7)
Ryan Parke — TEDx speaker, men's coach and author of How to Help Him — joins Adam Walker for the most personal episode on the Pharma Prescribed Podcast.
In June 2019, Ryan bumped into Brad's mum. Brad was the most successful man Ryan knew — fast car, big house, loving family. Brad had done everything we tell men in crisis to do: therapy, antidepressants, nightly calls home. Brad still died by suicide. That conversation sparked five years of research. This is what Ryan found.
For Adam, this is deeply personal. He has been working with Ryan through the hardest period of his life. This podcast was born from that work.
🎧 LISTEN ON YOUR PREFERRED APP
Spotify → https://open.spotify.com/episode/4MbArYNz1p0Iqa8zAtehgL?si=5YmL90LTSwafeDE2Igfj5w
Apple Podcasts → https://podcasts.apple.com/us/podcast/pharma-prescribed-with-ryan-parke-the-mens-coach-the/id1829715970?i=1000737770562
Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
Podbean → https://pharmaprescribed.podbean.com/

Youtube → https://youtu.be/zPiAYWwmGAQ?si=nApB-zW8ZLGEocQH
📖 WHAT WE COVER
- Brad's story — why doing everything right still wasn't enough
- The daylight savings heart attack spike: one lost hour kills more men on one specific day
- Testosterone: not aggression but a vital marker for metabolic health
- Low testosterone linked to suicide, depression, heart disease and prostate cancer
- Five lifestyle levers: diet, sleep, exercise, vitamin D3 and sobriety
- Steve: blood pressure dropped, type 2 diabetes reversed, testosterone doubled in 10 days
- Exercise 1.5x more effective than antidepressants and CBT for depression
- Each alcoholic drink may reduce testosterone by the equivalent of six years of aging
- The ALPHA Framework: five dimensions of male mental health
- Monday Morning Men's Club: 7am, locked at 7:01, five questions, 30 minutes
- Tough 21: daily check-ins producing 60–75% reductions in depression scores
- Adam's sobriety — and how this podcast came to exist
⏱️ CHAPTERS
0:00 Trigger warning and intro
1:00 Meet Ryan Parke
2:00 Brad's story — the most successful man Ryan knew
3:00 Brad did everything right — and still died
4:00 Research begins: one day a week from June 2019
5:00 The daylight savings heart attack spike
6:00 Why one lost hour hits men harder than women
7:00 Testosterone: the hormone everyone has wrong
8:00 Testosterone is calming — not aggressive
9:00 Low testosterone linked to suicide and depression
10:00 The biggest killers of men — and the testosterone thread
11:00 Flipping the narrative on male mental health
12:00 Natural vs synthetic testosterone
13:00 Testosterone as a marker for metabolic health
14:00 Five lifestyle levers — starting with diet
15:00 Real food, low carb and Ryan's personal experiment
16:00 From 20 to 30 nanomoles in eight months
17:00 Steve: blood pressure, diabetes, testosterone all reversed
18:00 Sleep: one missed hour = 12 years of testosterone aging
19:00 Sleep quality and shift work
20:00 Exercise: 150 minutes — and why it beats antidepressants
21:00 Vitamin D3: sunlight, wild fish and absorption
22:00 Sobriety: each drink = six years of testosterone aging
23:00 The 1% compound effect of sober decisions
24:00 Adam's sobriety and the rugby tour
25:00 "Sometimes trying to be a man is what kills men"
26:00 Fatherhood, Max and testosterone in new parenthood
27:00 Monday Morning Men's Club: 7am, locked at 7:01
28:00 Five questions, 30 minutes, accountability
29:00 The ALPHA Framework: five dimensions of male mental health
30:00 Achieving, body and mind, protecting the cave
31:00 Adventures, dopamine and purpose
32:00 Tough 21: 60–75% reduction in depression scores
33:00 Adam's 90 days — and how this podcast was born
34:00 How to Help Him: the book for women
35:00 Fact-checking 340 sources — and the parakeet study
36:00 Quick-fire round
37:00 A ship in harbour is safe — but that's not what ships are for
38:00 Courage, curiosity and commitment
39:00 Bill early, pay late — and where to find Ryan
40:00 Closing: why this podcast exists
👤 ABOUT RYAN PARKE
Ryan Parke is The Men's Coach — TEDx speaker, author of How to Help Him and creator of the ALPHA Framework and Tough 21. Works with NHS Trusts, schools and emergency services.
🌐 https://www.themenscoach.co.uk
📸 @ryanparketmc
📚 How to Help Him — Amazon, Waterstones, Barnes & Noble
🎙️ ABOUT PHARMA PRESCRIBED
Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
🌐 https://pharmaprescribed.com
💼 https://www.linkedin.com/in/adamwalkerbiometrics
#RyanParke #TheMensCoach #MensMentalHealth #Testosterone #MentalHealth #PharmaPrescribed #AdamWalker #ALPHAFramework #HowToHelpHim #MentalHealthUK #Samaritans #MaleWellbeing #SuicidePrevention #MondayMorningMensClub #Wellbeing
...more
55min
November 21, 2025 Validate, Then Trust, Then Verify: How AI Has to Earn Its Place in Your Data
Wendy Turenne on Real World Evidence, Messy Data & Why AI Must Earn Your Trust | Pharma Prescribed
Wendy Turenne — known industry-wide as Real World Wendy — joins Adam Walker for a conversation about data, storytelling and what it takes to turn messy healthcare information into decisions that matter.
Wendy is the child of two statisticians and a biostatistician herself. She spent 25+ years across providers, payers, health tech and government, most recently as Chief Data Officer and SVP at Aetion, leading global teams transforming real world data into regulatory-grade evidence. Now an independent consultant advising on data maturity and evidence strategy.
The woman who wasn't allowed to use stepwise regression in 1998 has some thoughts about AI.
🎧 LISTEN ON YOUR PREFERRED APP
Spotify → https://open.spotify.com/episode/6CiE5cylG1xe2NRcMwXEK8?si=6svPFaFkRGOItaYGmzyJXg
Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-with-wendy-turenne-real-world-wendy/id1829715970?i=1000737770129
Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
Podbean → https://www.podbean.com/ew/pb-areyf-19c236e
📖 WHAT WE COVER
- Child of two statisticians who tried to be a criminal prosecutor — ended up in biostats
- Dinner table debates about logistic regression between a survey statistician and an epidemiologist
- What "Real World Wendy" learned in seven years at Aetion
- COVID: buried in millions of rows while everyone else was on Clubhouse
- Clinical trials vs RWE — pieces of the same puzzle, not competitors
- "I am drawn to things that are messy and unanswerable"
- The toolbox metaphor: what's in yours and where does it feel fun to take it?
- Impatience in the next generation: catalyst or risk?
- Stepwise regression 1998: why constraints make you better with freedom
- Validate first, then trust, then verify — how AI must earn its place
- Women's health: the data exists, the mysteries can be unlocked
- Don't confuse change with failure
- Be honest and be kind
⏱️ CHAPTERS
0:00 Intro & podcast mission
1:00 Meet Wendy Turenne — Real World Wendy
2:00 Child of two statisticians — born this way
3:00 The teen who wanted to be a criminal prosecutor
4:00 "The information's here — just figuring it out"
5:00 Hospital data, kidney care and oncology
6:00 Dinner table: regression debates between parents
8:00 Seven years at Aetion and what RWE taught her
10:00 Multi-stakeholder groups and shutting down inconvenient perspectives
12:00 10-year-old Wendy wanted to be a pop star
13:00 "All that work loses its potential if you can't tell the story"
14:00 From SAS programmer to storytelling scientist
16:00 COVID: millions of rows while Clubhouse talked
18:00 Making everyone a better consumer of evidence
19:00 Clinical trials vs RWE explained simply
21:00 Why Wendy is drawn to messy, observational data
24:00 The toolbox metaphor
27:00 Impatience in the next generation
30:00 Stepwise regression in 1998 and learning in constraints
32:00 "Give me a chance" — Adam plays the other side
34:00 Break it — but put it back together
36:00 Women's health: data exists, tools are here
38:00 Validate, trust, verify — how AI earns its place
40:00 Quick-fire: stop being scared
41:00 Authenticity, transparency, roll-up-your-sleeves
42:00 Trip and Zacharia — Christmas in Bern, Zurich and Paris
43:00 Golden rule: be honest and be kind
👤 ABOUT WENDY TURENNE
Wendy Turenne is an independent RWD and evidence strategy consultant. Former CDO and SVP Evidence Solutions at Aetion. 25+ years across providers, payers, health tech and government. Known as Real World Wendy.
📧 [email protected]
💼 Search "Wendy Turenne" on LinkedIn
🎙️ ABOUT PHARMA PRESCRIBED
Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
🌐 https://pharmaprescribed.com
💼 https://www.linkedin.com/in/adam-walker-2327951/
#WendyTurenne #RealWorldWendy #RealWorldData #RWE #PharmaPrescribed #AdamWalker #Aetion #Biostatistics #WomensHealth #AIinPharma #EvidenceStrategy #LifeSciences #DataScience #ClinicalResearch #Storytelling
...more
55min
November 18, 2025 Why Your Quality Software Has 100 Buttons When You Need 5
Jan Krikava on Docuply, Affordable QMS & Why Small Pharma Deserves Better Tools | Pharma Prescribed
Jan Krikava — co-founder and managing director of Docuply — joins Adam Walker for a practical conversation about quality management, affordable compliance and building a pharma software startup from scratch in Germany.
Jan started at SAP, went self-employed at 25, founded a consulting company (KLQC) for regulated industries, then spent two years validating one idea: smaller pharma and biotech companies need quality management systems that work for them — not enterprise tools with a hundred buttons when they need five.
250 interviews later, Docuply was born. Adam sits on its scientific advisory board.
🎧 LISTEN ON YOUR PREFERRED APP
Spotify → https://open.spotify.com/episode/2bYOVKyVYkbsHsp6H9D11a?si=9NuEAhEoQUaUH73kR0MtoA
Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-with-jan-krikava-managing-director/id1829715970?i=1000737246858
Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
Podbean → https://www.podbean.com/ew/pb-egu2b-19c00f7
📖 WHAT WE COVER
- 250 interviews and a white paper: two-year validation before writing a line of code
- Why enterprise QMS platforms don't work for 10–150 person companies
- The pivot from document management to full electronic quality management
- "Quality doesn't have to cost a lot" — it just has too many repetitive tasks
- AI-generated SOP training questionnaires: upload a document, get questions in seconds
- What AI native means — and why cloud architecture makes it 10x easier
- The naming story: Doculab, a trademark dispute, and the Docuply brainstorm
- Bootstrapping to business angel funding — each right at the right time
- Fatherhood as fuel: becoming a dad two and a half years ago
- Brazilian jiu-jitsu as a hiring filter — a third of the team trains
- DACH focus first, Europe next, one US customer already
- Stay honest — to yourself and your partners
⏱️ CHAPTERS
0:00 Introduction & podcast mission
1:00 Meet Jan Krikava — co-founder of Docuply
2:00 From SAP to self-employment to founding KLQC
3:00 250 interviews: the two-year validation
4:00 Why pharma? Altruism, motivation and a market gap
5:00 Consistently motivated, kind people in pharma
6:00 The rollercoaster of a startup in regulated industries
7:00 Father and uncle both self-employed — entrepreneurial DNA
8:00 Fatherhood — responsibility as rocket fuel
9:00 Naming Docuply: trademark dispute to seven letters
10:00 The share symbol logo — documents should never be silos
11:00 The crowded market that isn't crowded when you zoom in
12:00 Enterprise hundred-button tools vs the five buttons you need
13:00 Setup fees and why small companies can't afford legacy QMS
14:00 Quality doesn't have to cost a lot
15:00 30 signatures for one SOP — and why that's absurd
16:00 AI-native features: LLMs, training questionnaires and CAPA
17:00 Digital natives entering quality management
18:00 The generational shift: systems must adapt
19:00 AI native explained: cloud architecture, 10x easier deployment
20:00 Mistral AI from France as technology partner
21:00 Bootstrapping to business angel funding
22:00 The German startup ecosystem
23:00 Advisory board and gathering pharma knowledge
24:00 DACH focus, European plans, one US customer
25:00 AI training questionnaires: upload, generate, evidence in seconds
26:00 Why Adam loves this feature
27:00 Quick-fire: do more things — collect experiences
28:00 Cultural fit, second-order thinking and Brazilian jiu-jitsu
29:00 Family: Jonathan and fatherhood
30:00 Golden rule: stay honest
👤 ABOUT JAN KRIKAVA
Jan Krikava is co-founder and MD of Docuply, a pre-validated eQMS for pharma and biotech. Software engineer, entrepreneur, SAP alumnus.
🌐 https://www.docuply.io
💼 Search "Jan Krikava" on LinkedIn
🎙️ ABOUT PHARMA PRESCRIBED
Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
🌐 https://pharmaprescribed.com
💼 https://www.linkedin.com/in/adam-walker-2327951/
#JanKrikava #Docuply #QualityManagement #eQMS #PharmaTech #PharmaPrescribed #AdamWalker #BiotechStartup #SOPTraining #AIinPharma #CAPA #GermanStartup #LifeSciences #RegulatoryCompliance #CloudQMS
...more
31min
November 06, 2025 She Found Undiagnosed Children With AI. They're Alive in Their Twenties Now.
Dr. Andree Bates on Pharma AI, Saving Lives with Data, HelloFresh of Medicine | Pharma Prescribed
Dr. Andree Bates — founder and CEO of Eularis and 22-year veteran of pharmaceutical AI — joins Adam Walker for the most technically visionary conversation on the Pharma Prescribed Podcast.
Andree grew up in Papua New Guinea and Japan, holds a PhD in neuroscience, and built machine learning models in her lab before most people knew what AI stood for. She digitized her first pharma company after telling the chairman what was wrong on the bullet train to Osaka. He said: "Fix it."
She's been fixing things ever since — from 94.8% market share prediction to finding undiagnosed ultra-rare disease children who are now alive in their twenties.
🎧 LISTEN ON YOUR PREFERRED APP
Spotify → https://open.spotify.com/episode/0ysC8NreYCBq4Co8uEaeaB?si=81Wh-bPGQL20EoAZtRYSng
Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-with-dr-andr%C3%A9e-bates-ceo-of/id1829715970?i=1000735563632
Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
Podbean → https://www.podbean.com/ew/pb-fpdvw-19aceff
📖 WHAT WE COVER
- The bullet train story: told the chairman what was wrong — he said fix it
- Papua New Guinea to Japan to London to New York: adaptability as superpower
- 94.8% accuracy predicting market share across thousands of brands
- Finding undiagnosed ultra-rare toddlers — now alive in their twenties
- Third-line cancer: triangulating EHR and claims data to find the doctor
- AI strategy blueprints: 50% off-the-shelf, 50% needs building
- Grail blood test: predicting 50+ cancers with no symptoms
- Brain cells on computer chips — Cortical Labs and Amazon
- Non-invasive brain interface letting paralysed people communicate in an hour
- Digital twins, personalised medicine and the HelloFresh of pharma
- "Trust the vision, be patient, be kinder to yourself during setbacks"
⏱️ CHAPTERS
0:00 Introduction & podcast mission
1:00 Meet Dr. Andree Bates — founder of Eularis
2:00 PhD neuroscience and ML in the lab
3:00 Papua New Guinea, Japan and why impact matters now
4:00 The bullet train: telling the chairman on day one
5:00 Digitizing pharma in Tokyo — world firsts with Glaxo
6:00 Starting Eularis: Pfizer in New York as first client
7:00 "50% of my marketing's wasted — fix that"
8:00 Ultra-rare disease: finding undiagnosed toddlers with AI
9:00 Those children are in their twenties now — alive
10:00 Cultural adaptability across countries
11:00 AI inflection points: GANs, data explosion, transformers
13:00 LLMs won't last — what comes next
14:00 Patient data privacy and federated learning
16:00 Third-line cancer: triangulating EHR and claims data
18:00 First, second, third line treatment explained
19:00 Elite AI teams: top 20 data scientists, 13 joined
21:00 Data scientists, engineers, DevOps and scrum
22:00 AI strategy blueprints: how Eularis advises pharma
24:00 50% off-the-shelf, 50% build
26:00 Training: the "LLMs are rubbish" moment
28:00 Jobs fear: saving hours without cutting people
30:00 Advice for the next generation
32:00 The Uber driver and the PhD intern from Uganda
33:00 Andree's vision — 12 hours in Virginia airport
34:00 Grail: 50+ cancers from a single blood draw
35:00 The listener who said "you saved my life"
36:00 Non-invasive brain interface vs Neuralink
38:00 Brain cells on chips: Cortical Labs and Amazon
39:00 Digital twins powered by your own brain
40:00 HelloFresh of pharma: 3D printed personalised drugs
42:00 Quick-fire: trust the vision but be patient
44:00 Curiosity, patient centricity, comfort with ambiguity
46:00 Flying, sailing and the Mekong Delta
48:00 Golden rule: do work that matters with people who matter
👤 ABOUT DR. ANDREE BATES
Founder and CEO of Eularis. PhD neuroscience. 22 years in pharma AI. Pilot. Weekly newsletter on AI and life sciences.
💼 Search "Dr Andree Bates" on LinkedIn
🎙️ ABOUT PHARMA PRESCRIBED
Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
🌐 https://pharmaprescribed.com
💼 https://www.linkedin.com/in/adam-walker-2327951/
#AndreeBates #Eularis #AIinPharma #PharmaceuticalAI #PharmaPrescribed #AdamWalker #RareDisease #DigitalTwins #Grail #CancerDiagnostics #MachineLearning #DrugDiscovery #LifeSciences #Neuroscience #FederatedLearning
...more
50min
October 28, 2025 The Two Things Alcohol Quietly Steals: Clarity and Consistency
Paul McCormack on Sobriety, Untapped Performance & Why Alcohol Steals Your Best Self | Pharma Prescribed
Paul McCormack — founder of Intention Performance and creator of the Untapped Performance Project — joins Adam Walker for the most personally resonant conversation on the Pharma Prescribed Podcast.
Paul grew up in the west of Scotland, where alcohol was the reward you earned with age. For nearly 20 years it was the connector — work drinks, football clubs, expat life in London and Sydney. Every October he'd take 30 days off, feel amazing, then count down to November 1st and four bottles of wine. Until COVID, a puppy called Rolo, and a 5am wake-up changed everything.
He hasn't had a drink in five years. Neither has Adam. This is that conversation.
🎧 LISTEN ON YOUR PREFERRED APP
Spotify → https://open.spotify.com/episode/4Vnz2NR4rk727FTukW4REI?si=oCtRjGIbRpeTpK_D3LYcMA
Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-with-paul-mccormack-founder-coach/id1829715970?i=1000733878494
Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
Podbean → https://www.podbean.com/ew/pb-gix2g-19a7efa
📖 WHAT WE COVER
- The October ritual: 30 days off, four bottles of wine waiting on November 1st
- COVID, a bottle of wine every night for six weeks, and a puppy called Rolo
- From 30 days to 100 to a year — and the 126 YouTube videos that got him there
- Stag do sober: how the guy who'd have called you insane did it and loved it
- FOMO to JOMO: the fear of missing out becomes the joy of missing out
- Fat Boy Slim sober: Adam's story from last night — two drank, two didn't, same joy
- Alcohol as an anesthetic: what it actually does to your senses
- Clarity and consistency: the two things alcohol steals that matter most
- The Untapped Performance Project: 30 days on alcohol, then performance coaching
- Ryan Parke's Future Self Program and Monday Morning Men's Club
- Coaching as the unsexiest, most effective investment you can make
- Atomic Habits and compound gains from daily sober decisions
- "Don't take yourself too seriously" — the golden rule
⏱️ CHAPTERS
0:00 Introduction & podcast mission
1:00 Meet Paul McCormack — founder of Intention Performance
2:00 Working with growth-minded men at 50-70% capacity
3:00 Growing up in Scotland: alcohol as a reward earned with age
4:00 University, London, Sydney — alcohol as the connector everywhere
5:00 The October ritual: 30 days off, four bottles waiting
6:00 Adam's own relationship with alcohol
7:00 COVID: a glass of wine every night for six weeks
8:00 Rolo the puppy and the 5am wake-up that changed everything
9:00 From 30 days to 100 — and 126 YouTube videos in the gap
10:00 The switch: logical reasons plus physical and mental benefits
11:00 First birthday sober since age 17
12:00 Career: journalism dream, HSBC, online gaming, marketing
14:00 Moving to Sydney at 27 with one suitcase
15:00 Going full-time coaching in 2024
16:00 The Future Self Program with Ryan Parke
17:00 Monday Morning Men's Club and goal setting
18:00 Adam's podcast origin story — born from the Future Self Program
20:00 The Untapped Performance Project explained
21:00 First 30 days: deep dive into the alcohol relationship
22:00 Values alignment and confronting the truth
23:00 FOMO to JOMO
24:00 Fat Boy Slim last night: two sober, two drinking, same experience
26:00 Alcohol as anesthetic — what it does to your senses
27:00 The stag do: sober, FaceTime with dad, pan au chocolat
28:00 Compound gains from showing up every day without alcohol
30:00 Clarity and consistency — the two things alcohol takes
32:00 Coaching: being listened to without someone scrolling their phone
34:00 Therapy, dog walks and investing time in yourself
36:00 Coaching for everyone — not just execs
37:00 Alcohol break + coaching = most productive three months ever
38:00 Quick-fire: trust the process
39:00 Authenticity, listening and openness to feedback
40:00 Golden rule: don't take yourself too seriously
41:00 How to connect: LinkedIn and untappedperformanceproject.com
👤 ABOUT PAUL MCCORMACK
Paul McCormack is founder of Intention Performance and creator of the Untapped Performance Project. Five years alcohol-free. Based in Sydney.
🌐 https://www.untappedperformanceproject.com
💼 Search "Coach Paul McCormack" on LinkedIn
🎙️ ABOUT PHARMA PRESCRIBED
Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
🌐 https://pharmaprescribed.com
💼 https://www.linkedin.com/in/adam-walker-2327951/
#PaulMcCormack #IntentionPerformance #AlcoholFree #Sobriety #PharmaPrescribed #AdamWalker #UntappedPerformance #MensMentalHealth #JOMO #FOMO #FutureSelf #RyanParke #AtomicHabits #Coaching #Wellbeing
...more
42min
October 25, 2025 A Chance Airport Conversation Became a Global Deal in a Year and 26 Days
Sverre Bengtsson on Building Viedoc, the Paris Airport Deal & Why Europe Must Work Together | Pharma Prescribed
Sverre Bengtsson — co-founder of Viedoc Technologies, ACDM board member and angel investor in 30+ life science ventures — joins Adam Walker for a conversation about building a global eClinical platform from a blank sheet of paper.
Sverre trained as a statistician in Sweden, got lured into clinical research by someone who said "you know a bit of statistics, can't you do things here?" — and never left. When his CRO employer hit hard times, he and co-founder Hendrik built their own EDC system, not for others, but for themselves. Competitors asked to use it. Then a chance encounter in a Paris airport lounge led to a global pharma deal that changed everything.
Viedoc now operates across 80+ countries. Sverre is focused on investing in the next generation.
🎧 LISTEN ON YOUR PREFERRED APP
Spotify → https://open.spotify.com/episode/7zSgUe1f80Bd483P9G8JuK?si=BQd1aCmAQoCnhMcdpxYl5Q
Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-with-sverre-bengtsson-digital-first/id1829715970?i=1000733465389
Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
Podbean → https://www.podbean.com/ew/pb-7gjtb-19a3574
📖 WHAT WE COVER
- Built an EDC system from a blank sheet of paper in 2003 — for themselves, not clients
- Competitors asked to use it — and Viedoc was born
- The Paris airport lounge: spotting a woman working on a pharma PowerPoint, demoing the system on the spot
- One year and 26 days: from lounge conversation to global pharma contract
- Splitting the CRO from the tech company — and why it had to happen for Viedoc to take off
- AI is hitting clinical operations first: protocols, trial management, feasibility analysis
- "We overestimate the short-term effects but underestimate the long-term effects"
- The radiologist problem: AI gets smarter, humans get lazier — and we lose knowledge
- Why a knowledge-intensive industry must keep attracting new talent even as AI scales
- ACDM, EUCROF and why volunteering matters
- Europe's fragmentation, competitiveness and the geopolitical imperative to work together
- 30+ angel investments across European life sciences
- Be humble. Do your best.
⏱️ CHAPTERS
0:00 Introduction & podcast mission
1:00 Meet Sverre Bengtsson — co-founder of Viedoc Technologies
2:00 Statistics, economics and how he got lured into clinical research
3:00 Building Viedoc from a blank sheet of paper in 2003
4:00 Competitors wanted to use it — the accidental product company
5:00 Can't thank your first clients enough
6:00 The Paris airport lounge: demoing Viedoc to a pharma executive
7:00 One year and 26 days to sign the global deal
8:00 60 pages of contract — the first time at that level
9:00 Splitting the CRO from the tech company — the hard decision
10:00 Firewall, trust and why the CRO had to be sold
11:00 Focus: the moment Viedoc truly took off
12:00 Scaling globally: 24/7 support, multiple IT centres, 80+ countries
13:00 AI hitting clinical operations first — protocols and feasibility
14:00 Live monitoring of operational and data quality
15:00 Conservative industry or inflection point? Both are right
16:00 Three to five years before this is mainstream
17:00 The radiologist problem: AI improves, human knowledge declines
18:00 Why we must keep attracting new talent into clinical research
19:00 The sweet spot of medical information, data and tech
20:00 Think outside the checklist
21:00 Mentors: MiniDoc founders and the CEO who made him stay
22:00 The balance between nerd and communicator
23:00 People in this industry genuinely burn for what they do
24:00 ACDM: how he got involved through volunteering
25:00 EUCROF: promoting the European perspective
26:00 Europe's challenges: fragmentation, competitiveness and unity
27:00 Geopolitics and working together globally
28:00 ACDM as a model for the world
29:00 Quick-fire: focus — his wife would agree
30:00 Golden rule: be humble, do your best
👤 ABOUT SVERRE BENGTSSON
Co-founder of Viedoc Technologies. ACDM board member. EUCROF member. Angel investor in 30+ European life science ventures. Statistician by training.
💼 Search "Sverre Bengtsson" on LinkedIn
🎙️ ABOUT PHARMA PRESCRIBED
Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
🌐 https://pharmaprescribed.com
💼 https://www.linkedin.com/in/adam-walker-2327951/
#SverreBengtsson #Viedoc #EDC #ClinicalTrials #ACDM #PharmaPrescribed #AdamWalker #eClinical #LifeSciences #ClinicalDataManagement #AngelInvestor #BiotechStartup #Europe #EUCROF #AIinPharma
...more
31min
October 16, 2025 60% of Patients Would Join a Trial. Only 8% Do. She Fixes It in 5 Minutes
Nuria Coll Bastus on ClinicalNet, Trial Matching in 5 Minutes & Why 80% of Trials Are Delayed | Pharma Prescribed
Nuria Coll Bastus — founder and CEO of ClinicalNet — joins Adam Walker for a conversation about why 80% of clinical trials are delayed by recruitment, and how one platform could change that.
Nuria has a PhD in onco-genomics from Barts Cancer Institute, spent years in pharma, and kept getting calls from friends and family: "Can you find a clinical trial for my loved one?" She could — but it took six hours. That disconnect became her MBA dissertation, then her startup, then her life's work.
ClinicalNet matches patients with clinical trials in under five minutes. Free. Globally.
🎧 LISTEN ON YOUR PREFERRED APP
Spotify → https://open.spotify.com/episode/6WpliuhaXzpXMgUXufcM5T?si=70dccc836434431e
Apple Podcasts → https://podcasts.apple.com/us/podcast/nuria-coll-bastus-on-clinicalnet-trial-matching-in/id1829715970?i=1000732142862
Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
Podbean → https://pharmaprescribed.podbean.com/
📖 WHAT WE COVER
- 60% of patients would consider a trial, but only 8% enter one — why?
- Six hours to search using expert skills most patients don't have
- ClinicalNet: matching in under five minutes, free, all indications
- 65,000 open trials structured by AI — why three AI teams failed before Nuria solved it
- The Barcelona oncologist who didn't know about two melanoma trials next door
- Nuria's mother diagnosed with metastatic melanoma — the personal story
- Updated every 24 hours: new trials surfaced automatically
- Less than 10% of traditional recruitment cost — fully automated
- Clinical trials as a day-one treatment option, not a last resort
- Don't give up — the golden rule
⏱️ CHAPTERS
0:00 Introduction & podcast mission
1:00 Meet Nuria Coll Bastus — founder of ClinicalNet
2:00 Chemistry in Barcelona to onco-genomics PhD at Barts
3:00 The disconnect: patients looking, trials struggling
4:00 MBA dissertation becomes a startup
5:00 Summer 2021: leaving pharma for the mission
6:00 Understanding business as much as science
7:00 Only 20% of patients try a second search
8:00 What families actually experience looking for trials
9:00 ClinicalNet: five minutes, lay and medical language
10:00 Building the AI — three teams failed before Nuria solved it
11:00 Why LLMs alone can't process 65,000 trials at scale
12:00 Breaking down data from a medical perspective
13:00 "Not pregnant" vs "negative HCG test" — the data problem
14:00 Free for patients, doctors and academic trials — always
15:00 Updated every 24 hours with new trials
16:00 Pharma pays: less than 10% of traditional recruitment cost
17:00 No army of PhDs — everything automated
18:00 When all three user groups connect, it works
20:00 Three years to build a scalable platform
21:00 Profitability expected within nine to twelve months
22:00 The colleague whose husband had metastatic gastric cancer
24:00 Nuria's mother and the Barcelona melanoma diagnosis
25:00 The oncologist who didn't know about two nearby trials
26:00 "It's the job of the family to take care of your own health"
28:00 Patients already entering trials through ClinicalNet
29:00 Trials as day-one options, not last resort
30:00 Taking ownership of health outcomes
33:00 NIHR conversations and NHS app potential
35:00 Quick-fire: don't be scared — start sooner
36:00 Motivation for impact, honesty, positivity
37:00 Sport — any sport
38:00 Golden rule: don't give up
👤 ABOUT NURIA COLL BASTUS
Founder and CEO of ClinicalNet. PhD onco-genomics (Barts). 12+ years in drug development.
🌐 https://www.clinicalnet.com
🔍 https://trials.clinicalnet.com (free patient search)
💼 Search "Nuria Coll Bastus" on LinkedIn
🎙️ ABOUT PHARMA PRESCRIBED
Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
🌐 https://pharmaprescribed.com
💼 https://www.linkedin.com/in/adam-walker-2327951/
#NuriaCollBastus #ClinicalNet #PatientRecruitment #ClinicalTrials #PharmaPrescribed #AdamWalker #HealthTech #OncoGenomics #CancerTrials #PatientAccess #DrugDevelopment #LifeSciences #AIHealthcare #FemaleFounder #Barcelona
...more
39min

FAQs about Adam Walker’s Pharma Prescribed Podcast:

How many episodes does Adam Walker’s Pharma Prescribed Podcast have?

The podcast currently has 55 episodes available.